Entity

Time filter

Source Type

Hiratsuka, Japan

Tokai University is a private university in Tokyo, Japan. It was established in 1943 by Shigeyoshi Matsumae, who had formerly been the engineering president of the Ministry of Communications. The Shonan Campus was established in the 1960s.Tōkai University is unique amongst Japanese universities in referring to its faculties as "schools." Special features of the university include the Department of Nordic Studies, including instruction in languages. The university also offers pilot training in cooperation with All Nippon Airways. The university has focused particularly on the science and engineering, as the founder believed that "After the war, development and the peaceful use of the science and technology were necessary for the development of Japan where the resource was scarce" About 60 percent of students enrolled in those schools. Between 1994 and 2004, Tōkai University led all universities in Japan in the registration of new patents. Wikipedia.


Patent
Japan Stent Technology Co., Hiroo Iwata, Toyo Advanced Technologies Co. and Tokai University | Date: 2012-06-08

A stent includes a stent body of a cylindrical configuration having outer and inner surfaces, a first coated layer coating at least the outer surface, and a second coated layer coating substantially completely over the first coated layer. The first coated layer is prepared of a first composition comprising a polymer and a vascular intimal hyperplasia inhibitor (preferably argatroban) of a kind, which does not inhibit proliferation of endothelial cells, the weight compositional ratio of the polymer to the inhibitor being within the range of 8:2 to 3:7. On the other hand, the second coated layer is prepared of a polymer alone or a second composition comprising a polymer and a drug, the weight compositional ratio of the drug to 80% by weight of the polymer being less than 20% by weight.


Patent
Nihon Kohden, Tokai University and Waseda University | Date: 2013-03-07

An apparatus for determining sleep apnea includes: an expiratory gas collector which is configured to collect an expiratory gas of a subject; an analyzer which is configured to analyze a constituent and a concentration of the constituent in the collected expiratory gas; and a determiner which is configured to determine whether the subject is in sleep apnea or not, based on a concentration of at least VOC in the analyzed expiratory gas.


Patent
Comet Corporation and Tokai University | Date: 2012-08-29

A method and an apparatus capable of selectively damaging and killing tumor cells includes a step of irradiating tumor cells with a UV pulse flash having continuous emission spectra ranging at least from 230 to 270 nm, outside a living body of a human or a living body of a non-human animal or in a living body of a non-human animal. The UV pulse flash may have an accumulated irradiation amount per unit area that is achieved at a distance of 8 cm from a light source having an integrated output of, for example, 90, 180-7100 or 14200 J.


Patent
Tokai University | Date: 2012-11-30

Disclosed is a thermoacoustic engine having: resonance pipes including a working gas; motors; and a branch pipe, where each of the motors has a regenerator, a heater, and a cooler, a temperature gradient is given between both ends of the regenerator to generate self-excited oscillation of the working gas, a channel cross-sectional area of the resonance pipe that is coupled to the heater is expanded by a same amplification factor of a work flow based on the self-excited oscillation or by an amplification factor within a range of 30% of the amplification factor of the work flow to a channel cross-sectional area of a resonance pipe that is coupled to the cooler, and a channel cross-sectional area of the regenerator is set by 4 to 36 times of the channel cross-sectional area of the resonance pipe that is coupled to the cooler.


Patent
Toyo Advanced Technologies Co., Tokai University and Janpan Stent Technology Co. | Date: 2012-12-28

A method of making a stent, including preparing a solution containing a composition, the composition comprising a biodegradable polymer and a vascular intimal hyperplasia inhibitor of a kind, including argatroban, which does not inhibit proliferation of endothelial cells, the weight compositional ratio of the polymer to the vascular intimal hyperplasia inhibitor being within the range of 8:2 to 3:7, the composition dissolved in a solvent selected from the group consisting of a mixture of a lower alkyl ketone and methanol, a mixture of a lower alkyl ester and methanol or a mixture of a lower halogenated hydrocarbon and methanol; coating at least an outer surface of a stent body of a cylindrical configuration having outer and inner surfaces with a diamond-like thin film coated on the surfaces; and after the coating, removing the solvent to complete a first coated layer.

Discover hidden collaborations